NTBI in the Brain

Extending the NTBI Story to the CNS

The existing note on Iron Overload and NTBI covers systemic NTBI. This note focuses specifically on whether and how NTBI reaches the brain, and what happens when it does.

flowchart TD
    A["TSAT Above 45%"] --> B["NTBI in Circulation"]
    B --> C["Reaches BBB"]
    C --> D["Non-Regulated Uptake"]
    D --> E["ZIP8 / ZIP14 / DMT1"]
    E --> F["Iron Enters Neurons and Glia"]
    F --> G["Fenton Chemistry"]
    G --> H["ROS Generation"]
    H --> I["Regional Vulnerability"]

    I --> J["Substantia Nigra"]
    I --> K["Basal Ganglia"]
    I --> L["Hippocampus"]

    F --> M["CSF Tf 100% Saturated"]
    M --> N["Zero Buffering Capacity"]
    N --> O["Free Iron Immediately Toxic"]
    O --> G

    H --> P["Ferroptosis"]
    H --> Q["Neuroinflammation"]
    Q --> R["More Iron Retention"]
    R --> F

    classDef pathological fill:#f1948a,stroke:#c0392b,color:#1a0505
    classDef vulnerable fill:#f5b7b1,stroke:#e74c3c,color:#1a0505
    classDef neutral fill:#85c1e9,stroke:#2471a3,color:#0a1929

    class A,B,G,H,O,P,Q,R pathological
    class J,K,L vulnerable
    class C,D,E,F,I,M,N neutral

Does NTBI Cross the Blood-Brain Barrier?

Yes, but slowly and via specific mechanisms.

Tripathi AK et al. "Transport of non-transferrin bound iron to the brain: implications for Alzheimer's disease." J Alzheimers Dis. 2017;58(4):1109-1119. PMC5637099

• Iron-labeled NTBI was detected in the brain ventricular system after 2 hours and brain parenchyma after 24 hours
• NTBI is transported to the brain at a much slower rate than transferrin-bound iron
• But it enters via unregulated pathways — not subject to the normal transferrin receptor-mediated control

Transport Mechanisms

Knutson MD. "Non-transferrin-bound iron transporters." Free Radic Biol Med. 2019;133:101-111. DOI: 10.1016/j.freeradbiomed.2018.10.413

• NTBI uptake involves:
  • Reduction of extracellular Fe3+ to Fe2+ by ferrireductases
  • Import via ZIP8 (SLC39A8) and ZIP14 (SLC39A14) — divalent metal ion transporters
  • DMT1 in some cell types
• These transporters are NOT regulated by cellular iron levels the way TfR1 is
• Cells cannot shut off NTBI uptake when iron-replete

Brain Cell-Type Uptake

Bishop GM et al. "Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia." Neurotox Res. 2011;19(3):443-451. DOI: 10.1007/s12640-010-9195-x

• All three major brain cell types can accumulate NTBI
• Neurons, astrocytes, and microglia take up NTBI through distinct mechanisms
• NTBI uptake is not downregulated when cells are iron-loaded — a critical vulnerability

CSF Transferrin — Zero Buffer Capacity

A critically important fact:

Unlike serum transferrin (30-40% saturated), CSF transferrin is 100% saturated.

This means:

• Any iron released into the CSF or brain extracellular space cannot be buffered by transferrin
• Free iron in the brain extracellular space is immediately toxic via Fenton chemistry
• The brain relies entirely on cellular uptake, ferritin storage, and local hepcidin regulation to manage iron

NTBI and Neuroinflammation

Urrutia PJ et al. "Aberrant cerebral iron trafficking co-morbid with chronic inflammation: molecular mechanisms and pharmacologic intervention." Front Neurol. 2022;13:855751

• Chronic neuroinflammation alters iron trafficking at the BBB
• Inflammatory cytokines increase iron retention in brain endothelial cells
• Creates conditions where more iron enters the brain parenchyma
• NTBI generation within the brain (from damaged cells releasing iron) amplifies the process

Relevance to HFE Carriers

For someone with C282Y/H63D and TSAT 60%:

1. TSAT 60% is in the range where circulating NTBI appears (typically >45-50%)
2. Circulating NTBI can reach the BBB and slowly enter the brain
3. Once in the brain, NTBI enters cells via unregulated ZIP8/ZIP14/DMT1 pathways
4. Brain cells cannot refuse NTBI entry — no downregulation mechanism
5. CSF provides zero buffering for any iron released extracellularly
6. This creates a slow but relentless accumulation of brain iron in overload states

Regional Vulnerability

Brain regions with the highest baseline iron (basal ganglia, substantia nigra) are likely most affected because:

• They already have high metabolic iron turnover
• More iron means more potential for NTBI formation locally (when cells are damaged or release iron)
• Less reserve capacity to buffer additional iron

NTBI Generation Within the Brain

NTBI is not only imported from blood — it can be generated within the brain:

• Ferroptotic neurons release iron as they die
• Haemorrhage (even microhaemorrhage) releases haemoglobin-derived iron
• Demyelination releases iron from oligodendrocytes
• This locally-generated NTBI is immediately toxic in the zero-buffer CSF environment

Verified Academic Citations

You L, Yu PP, Dong T et al. "Astrocyte-derived hepcidin controls iron traffic at the blood-brain-barrier via regulating ferroportin 1 of microvascular endothelial cells." Cell Death Dis. 2022;13(8):689. PMID: 35915080

• Demonstrated that astrocyte-derived hepcidin regulates ferroportin on BBB endothelial cells, controlling iron entry into the brain
• When astrocytic hepcidin is upregulated (e.g., by inflammation), ferroportin is degraded and iron is trapped in endothelial cells or released into the brain parenchyma
• Establishes the brain hepcidin-ferroportin axis as a local regulatory mechanism distinct from systemic hepcidin

Duck KA, Simpson IA, Connor JR. "Regulatory mechanisms for iron transport across the blood-brain barrier." Biochem Biophys Res Commun. 2017;494(1-2):70-75. PMID: 29054412

• Demonstrated that BBB endothelial cells have their own iron requirements separate from their transport function
• Regional regulation of brain iron uptake involves neuron-to-endothelial signalling — neurons can signal increased iron demand
• Current BBB iron transport models are incomplete and do not account for regional or cell-type-specific regulation

Baringer SL, Palsa K, Simpson IA, Connor JR. "Apo- and holo-transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier." Mol Brain. 2023. PMID: 36712094

• Apo-transferrin (iron-free) and holo-transferrin (iron-loaded) have opposite effects on iron release from BBB endothelial cells
• Apo-transferrin stimulates iron release from the abluminal side (into brain), while holo-transferrin inhibits it
• This is a sensing mechanism: when brain iron is low (more apo-Tf), more iron is released into the brain; when brain iron is adequate (more holo-Tf), release is suppressed
• Relevant to HFE carriers: high systemic TSAT means more holo-Tf at the BBB, which should suppress iron release — but HFE variants may disrupt this feedback

Mezzanotte M, Ammirata G, Boido M et al. "Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic-neuronal crosstalk to counteract iron dyshomeostasis during aging." Sci Rep. 2022;12:11724. PMID: 35810203

• Brain hepcidin-ferroportin pathway becomes activated during ageing as a compensatory response to increasing brain iron
• Astrocyte-neuron crosstalk is central to this regulation
• Age-related failure of this compensatory mechanism may explain progressive brain iron accumulation in neurodegenerative conditions

Wei B, Liu W, Jin L et al. "Hepcidin depending on astrocytic NEO1 ameliorates blood-brain barrier dysfunction after subarachnoid hemorrhage." Cell Death Dis. 2024;15:575. PMID: 39107268

• Astrocytic hepcidin protects BBB integrity after haemorrhagic injury via NEO1-dependent signalling
• Brain hepcidin has neuroprotective functions beyond iron regulation — it directly maintains BBB structural integrity
• Relevant to NTBI: BBB disruption from any cause increases NTBI entry into the brain parenchyma

Cross-References

• Iron Overload and NTBI
• Hepcidin and Brain Iron Regulation
• Ferroptosis and Neuronal Iron
• HFE Variants and Brain Iron
• Transferrin Saturation - Clinical Significance
• Health Research MOC